See All Slides - tctmd.com

Slides

Presentation TCT 2012

Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step!

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

Presenter: Rasha Al-Lamee

October 23, 2012

Presentation TCT 2012

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Presenter: Thomas McNamara

October 23, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Introduction(9)

Presenter: Karthik Ananthasubramaniam

October 23, 2012

Presentation TCT 2012

Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

Radial Artery Hemostasis and Occlusion

Presenter: Samir Pancholy

October 23, 2012

Advertisement

Slides

Early Cellular Interaction and Biomaterials: Bioabsorbable Polymers and Advanced Metallic Surfaces Are the Next Logical Step!

TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group...

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Autologous Cardiac Stem Cells in VAD Patients

Introduction(9)

Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

HFPEF: Overview of Pathophysiology and Therapies

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Radial Artery Hemostasis and Occlusion

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content